News
CARDIFF, UNITED KINGDOM / ACCESS Newswire / June 18, 2025 / When it comes to type 1 diabetes, treating this chronic condition ...
About a month ago, I woke up without hearing in my left ear. I initially suspected a wax blockage or a blocked eustachian ...
Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas.
Although it has been suggested that the exit tunnel is simply a convenient route of egress for the nascent chain, specific protein sequences serve to slow the rate of translation, suggesting some ...
Enter journal, DOI, article type, keywords, authors, etc. Quick Search in Journals Enter journal, DOI, article type, keywords, authors, etc.
Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...
Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 ...
The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into ...
Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...
Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results